* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 2-years postdoctoral fellowship in the CIIL
Survey
Document related concepts
Trichinosis wikipedia , lookup
Leptospirosis wikipedia , lookup
Sexually transmitted infection wikipedia , lookup
Marburg virus disease wikipedia , lookup
Chagas disease wikipedia , lookup
Sarcocystis wikipedia , lookup
Hepatitis C wikipedia , lookup
Human cytomegalovirus wikipedia , lookup
African trypanosomiasis wikipedia , lookup
Schistosomiasis wikipedia , lookup
Hepatitis B wikipedia , lookup
Dirofilaria immitis wikipedia , lookup
Oesophagostomum wikipedia , lookup
Neonatal infection wikipedia , lookup
Hospital-acquired infection wikipedia , lookup
Transcript
2-years postdoctoral fellowship in the CIILTeam Lung infection and innate immunity Starting in December 2014 at Pasteur Institute (Lille) Description of the Topic: Lung inflammatory disorders such as chronic obstructive pulmonary disease (COPD) are associated with an increased susceptibility to respiratory infections which trigger episodes of exacerbation, a phenomenon that is clinically of increasing importance. Our aim is to better define the molecular mechanisms involved in the altered immunity present during COPD. Indeed, it is essential to adapt the immunotherapeutic approach (including vaccination) to this particular context. To reach this aim, we have developed murine models of acute exacerbation in COPD and in vitro approaches which have been designed to mimic as closely as possible the human pathology. A precise survey of pulmonary immune response (cell phenotype and functions, cytokine network) has been performed to better understand the mechanisms leading to the altered innate response. We have identified new mechanisms of susceptibility in this context and we would like to corroborate these data in the relevant clinical situation. In this context, the overall goal of this proposal is to evaluate the efficacy and the safety of new therapeutic approaches in our mouse model of COPD exacerbation, based on inhalation to cigarette smoke, intercalated with S. pneumoniae infection and to establish a proof of concept in human cell models. The capacity of these therapies to trigger efficient and safe host defense mechanisms, to control the infection and to limit the progression of the disease will be measured. This project will also precise the signature of the response to the different treatments during COPD. The candidate should have a PhD and the desire to undertake a first or second postdoctoral fellowship. You should already have a validated experience in experimental models (animal experimentation accreditation is required) and in immunology. Some knowledge about the mechanisms involved in lung inflammation and diseases will be appreciated. We seek autonomous, enthusiastic and energetic people with strong teamwork skills. Contacts: Pichavant Muriel ([email protected]) Gosset Philippe ([email protected])